These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33988379)

  • 21. Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents.
    Li Z; Chen Y; Zhou Z; Deng L; Xu Y; Hu L; Liu B; Zhang L
    Eur J Med Chem; 2019 Feb; 164():352-365. PubMed ID: 30605833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARδ activation protects endothelial function in diabetic mice.
    Tian XY; Wong WT; Wang N; Lu Y; Cheang WS; Liu J; Liu L; Liu Y; Lee SS; Chen ZY; Cooke JP; Yao X; Huang Y
    Diabetes; 2012 Dec; 61(12):3285-93. PubMed ID: 22933110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.
    Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ
    Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation.
    Schnegg CI; Greene-Schloesser D; Kooshki M; Payne VS; Hsu FC; Robbins ME
    Free Radic Biol Med; 2013 Aug; 61():1-9. PubMed ID: 23499837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516.
    Lagu B; Kluge AF; Goddeeris MM; Tozzo E; Fredenburg RA; Chellur S; Senaiar RS; Jaleel M; Babu DRK; Tiwari NK; Takahashi T; Patane MA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):533-536. PubMed ID: 29275935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.
    Mosti MP; Stunes AK; Ericsson M; Pullisaar H; Reseland JE; Shabestari M; Eriksen EF; Syversen U
    Endocrinology; 2014 Jun; 155(6):2178-89. PubMed ID: 24708238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BSNXD modulates mesenchymal stem cell differentiation into osteoblasts in a postmenopausal osteoporotic mouse model.
    Qiu XM; Wang L; Gui YY; Xu YP; Li DJ
    Int J Clin Exp Pathol; 2015; 8(5):4408-17. PubMed ID: 26191132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.
    Ji MJ; Yu XB; Mei ZL; An YQ; Tang SS; Hu M; Long Y; Miao MX; Hu QH; Sun HB; Kong LY; Hong H
    Int J Neuropsychopharmacol; 2015 Sep; 19(1):. PubMed ID: 26362775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.
    Zhang R; Deangelis A; Wang A; Sieber-McMaster E; Li X; Russell R; Pelton P; Xu J; Zhu P; Zhou L; Demarest K; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1101-4. PubMed ID: 19168353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor δ promotes the progression of posttraumatic osteoarthritis in a mouse model.
    Ratneswaran A; LeBlanc EA; Walser E; Welch I; Mort JS; Borradaile N; Beier F
    Arthritis Rheumatol; 2015 Feb; 67(2):454-64. PubMed ID: 25331977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
    Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
    Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligands.
    Miyachi H
    Curr Med Chem; 2007; 14(22):2335-43. PubMed ID: 17896982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
    Chen ZC; Lee KS; Chen LJ; Wang LY; Niu HS; Cheng JT
    PLoS One; 2013; 8(5):e64229. PubMed ID: 23724037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
    Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
    Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
    Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
    Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.
    Yue TL; Nerurkar SS; Bao W; Jucker BM; Sarov-Blat L; Steplewski K; Ohlstein EH; Willette RN
    J Pharmacol Exp Ther; 2008 May; 325(2):466-74. PubMed ID: 18287212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.